Parties have selected three Elmiron lawsuits to serve as the first early bellwether trial test cases over vision loss claims linked to the bladder pain drug.
An Elmiron lawsuit claims the manufacturers failed to warn patients that the interstitial cystitis drug could cause vision damage and retinal changes.
The Paragard lawsuit indicates a woman had to undergo multiple surgeries to have the broken arms of the birth control device removed from her uterus.
A U.S. District Judge is calling for plaintiffs to turn in all Elmiron claim information before bellwether cases are selected next month.
A lawsuit filed of Elmiron retinal damage claims the bladder pain drug caused a woman to suffer distorted and blurred vision due to retinal damage.
Elmiron cases filed in New Jersey state courts will be consolidated as part of a multicounty litigation for pretrial proceedures.
An Elmiron Science Day has been scheduled for March, to help educate the court on the science behind claims of vision loss associated with the bladder pain drug.
Drug makers avoided clinical testing that may have identified the eye injury risks from Elmiron before the drug was placed on the market.
Elmiron lawyers meet next week with a federal judge to discuss the next steps in preparing the first vision loss lawsuits for trial in 2023.
Johnson & Johnson, Teva and other drug manufacturers won a bench decision in an opioid crisis trial in California, after the judge ruled there was no evidence linking the companies'…